[go: up one dir, main page]

WO2008153135A1 - Naphthalene derivative - Google Patents

Naphthalene derivative Download PDF

Info

Publication number
WO2008153135A1
WO2008153135A1 PCT/JP2008/060865 JP2008060865W WO2008153135A1 WO 2008153135 A1 WO2008153135 A1 WO 2008153135A1 JP 2008060865 W JP2008060865 W JP 2008060865W WO 2008153135 A1 WO2008153135 A1 WO 2008153135A1
Authority
WO
WIPO (PCT)
Prior art keywords
hydrogen atom
optionally substituted
independently represent
different
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/060865
Other languages
French (fr)
Japanese (ja)
Inventor
Hiroyuki Nakahira
Hitoshi Hochigai
Yohei Ikuma
Atsushi Suwa
Junya Ikeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Publication of WO2008153135A1 publication Critical patent/WO2008153135A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Disclosed is a compound represented by the formula (I) below or a pharmaceutically acceptable salt thereof, which is useful as a renin inhibitor. (I) (In the formula, R1a represents an optionally substituted C1-6 alkoxy group or the like; R1b and R1e may be the same or different and independently represent a hydrogen atom, a halogen atom or the like; R1c and R1d may be the same or different and independently represent a hydrogen atom, a halogen atom or the like; R1f and R1g may be the same or different and independently represent a hydrogen atom, a halogen atom or the like; R2 represents an optionally substituted C1-6 alkyl group or the like; R3a, R3b, R3c and R3d may be the same or different and independently represent an -A-B group (wherein A represents a single bond, a -(CH2)sO- group or the like, and B represents a hydrogen atom, an optionally substituted C1-6 alkyl group or the like); R4 represents a hydrogen atom, an optionally substituted C1-6 alkyl group or the like; s represents 0 or the like; and n represents 1 or the like.)
PCT/JP2008/060865 2007-06-14 2008-06-13 Naphthalene derivative Ceased WO2008153135A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007158075A JP2010189275A (en) 2007-06-14 2007-06-14 Naphthalene derivative
JP2007-158075 2007-06-14

Publications (1)

Publication Number Publication Date
WO2008153135A1 true WO2008153135A1 (en) 2008-12-18

Family

ID=40129738

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/060865 Ceased WO2008153135A1 (en) 2007-06-14 2008-06-13 Naphthalene derivative

Country Status (2)

Country Link
JP (1) JP2010189275A (en)
WO (1) WO2008153135A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010150840A1 (en) 2009-06-24 2010-12-29 大日本住友製薬株式会社 N-substituted-cyclic amino derivative
US8389511B2 (en) 2007-12-19 2013-03-05 Dainippon Sumitomo Pharma Co., Ltd. Bicyclic heterocyclic derivative
US8466282B2 (en) 2008-06-19 2013-06-18 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004111003A1 (en) * 2003-06-17 2004-12-23 Pfizer Limited Amide derivatives as selective serotonin re-uptake inhibitors
WO2006066896A2 (en) * 2004-12-23 2006-06-29 Novartis Ag Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
JP2006522793A (en) * 2003-04-10 2006-10-05 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー Piperidine derivatives as renin inhibitors for the treatment of hypertension
JP2006527758A (en) * 2003-06-17 2006-12-07 ファイザー インコーポレイテッド N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline reuptake inhibitors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006522793A (en) * 2003-04-10 2006-10-05 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー Piperidine derivatives as renin inhibitors for the treatment of hypertension
WO2004111003A1 (en) * 2003-06-17 2004-12-23 Pfizer Limited Amide derivatives as selective serotonin re-uptake inhibitors
JP2006527758A (en) * 2003-06-17 2006-12-07 ファイザー インコーポレイテッド N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline reuptake inhibitors
WO2006066896A2 (en) * 2004-12-23 2006-06-29 Novartis Ag Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8389511B2 (en) 2007-12-19 2013-03-05 Dainippon Sumitomo Pharma Co., Ltd. Bicyclic heterocyclic derivative
US8466282B2 (en) 2008-06-19 2013-06-18 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US8664380B2 (en) 2008-06-19 2014-03-04 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US9045436B2 (en) 2008-06-19 2015-06-02 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US9221836B2 (en) 2008-06-19 2015-12-29 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
WO2010150840A1 (en) 2009-06-24 2010-12-29 大日本住友製薬株式会社 N-substituted-cyclic amino derivative
US8658639B2 (en) 2009-06-24 2014-02-25 Dainippon Sumitomo Pharma Co., Ltd N-substituted-cyclic amino derivative

Also Published As

Publication number Publication date
JP2010189275A (en) 2010-09-02

Similar Documents

Publication Publication Date Title
WO2008136457A1 (en) Nitrogen-containing aromatic derivative
WO2009078481A1 (en) Bicyclic heterocyclic derivative
WO2009054479A1 (en) Spiro-ring compound and use thereof for medical purposes
WO2009048101A1 (en) Amide compound
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
WO2008093737A1 (en) Amide derivative
WO2010066629A3 (en) Novel azaindoles
WO2008096829A1 (en) Tricyclic compounds
WO2008096820A1 (en) Biphenyl derivative
WO2008146914A1 (en) Heterocyclic compound
WO2008149834A1 (en) Pyrimidodiazepinone derivative
WO2007103508A3 (en) Ligands for nematode nuclear receptors and uses thereof
WO2009063990A1 (en) Benzazepinone compound
WO2009005002A1 (en) Quinolone derivative
MX2010001566A (en) Aminopyrazole amide derivative.
WO2009014217A1 (en) Bicyclic pyrrole derivative
WO2008136385A1 (en) Amide compound and use thereof
SI2132204T1 (en) Crystalline forms of an 8-azabicyclos3.2.1coctane compound
WO2006039250A3 (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
WO2009063991A1 (en) Pyridooxazepine derivative and use thereof
WO2008153135A1 (en) Naphthalene derivative
WO2009072649A1 (en) 4-arylphenyl derivative
WO2007062308A3 (en) Homo- and heterocyclic compounds suitable as cetp inhibitors
EP2239254A4 (en) Benzylpiperizine compound
WO2007119004A3 (en) Method for diagnosing in vitro or ex vivo psychiatric disorders and/or intestinal dysbioses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08765575

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08765575

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP